Published in Clin Infect Dis on March 01, 2004
Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology (2010) 1.51
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection. Haemophilia (2009) 0.96
Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis (2010) 0.90
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis (2010) 0.89
Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients. AIDS Res Treat (2010) 0.88
Antiretroviral-associated Hepatotoxicity. Curr Infect Dis Rep (2005) 0.84
Association of high viral load and abnormal liver function with high aflatoxin B1-albumin adduct levels in HIV-positive Ghanaians: preliminary observations. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.83
An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. J Subst Abuse Treat (2014) 0.79
Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan. Surg Today (2011) 0.75